Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled vs Chewable Aspirin PK/PD in Healthy Adults
NCT04328883Phase 1Completed
- Sponsor
- Inova Health System
- Start
- Jul 2019
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aspirin in myocardial infarction (MI) (3 arms), sponsored by Inova Health System. Primary endpoint: Arachidonic acid (AA)-induced platelet aggregation at 24 hours. Started Jul 2019; status: completed.
02
Drugs
aspirin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT04328883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04328883.